A Phase 1 Study of the DOT1L Inhibitor, Pinometostat (EPZ-5676), in Adults with Relapsed or Refractory Leukemia: Safety, Clinical Activity, Exposure and Target Inhibition

This article has no abstract
Epistemonikos ID: 0efd96b360d4017d1ca94d5f1bbfa2fd23e2cff0
First added on: Feb 19, 2025